For insurers
The opioid epidemic is deadlier and costlier than ever. Ophelia improves access while greatly reducing costs for opioid use disorder treatment.
Save lives + reduce costs
Ophelia’s evidence-based MAT care model is considered the gold standard by the CDC, WHO, SAMHSA, AMA, and ASAM.
Fewer ER visits + hospitalizations
Our evidence-based treatment gets to patients before they get to the ER. By getting to them early, we’re reducing costs associated with overdose hospitalizations, ER visits, ambulance costs, and outpatient laboratory testing.
Greater adherence to care
By retaining patients on MAT for longer, we directly reduce overdose and relapse rates, consequently reducing readmission rates.
7 days a week + evening appointments
We’re available morning, afternoon, and evening to offer care for patients – something that not all providers do.
Partnering with the world’s leading insurers
We engage and treat the whole OUD population
The ones you know about, and the ones you never will.
MAT leads to:
Spend less than any other treatment program with Ophelia
Total cost per patient per month for the first three months post OUD diagnosis4
Ophelia in the news
Ophelia partners with UPenn and Yale to provide addiction training
The first-of-its-kind course was piloted at the University of Pennsylvania School of Nursing last winter and the Yale School of Nursing,
What our patients are saying
Research & Insights
Scientific research is at the core of what we do. Explore the following resources on OUD below.
Partner with Ophelia.
See results.
Find out more about how you can reduce costs and improve care.